Issue 1, 2012

From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling

Abstract

A pharmacophore describes the arrangement of molecular features a ligand must contain to efficaciously bind a receptor. Pharmacophore models are developed to improve molecular understanding of ligandprotein interactions, and can be used as a tool to identify novel compounds that fulfil the pharmacophore requirements and have a high probability of being biologically active. Protein structure-based pharmacophores (SBPs) derive these molecular features by conversion of protein properties to reciprocal ligand space. Unlike ligand-based pharmacophore models, which require templates of ligands in their bioactive conformation, SBPs do not depend on ligand information. The current review describes the different steps in the construction of SBPs: (i) protein structure preparation, (ii) binding site detection, (iii) pharmacophore feature definition, and (iv) pharmacophore feature selection. We show that the SBP modeling workflow poses different challenges than ligand-based pharmacophore modeling, including the definition of protein pharmacophore features essential for ligand binding. A comprehensive overview of different SBP modeling and screening methods and applications is provided to illustrate that SBPs can be efficiently used for virtual screening, ligand binding mode prediction, and binding site similarity detection. Our review demonstrates that SBPs are valuable tools for hit and lead optimization, compound library design and target hopping, especially in cases where ligand information is scarce.

Graphical abstract: From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling

Article information

Article type
Review Article
Submitted
17 Aug 2011
Accepted
08 Nov 2011
First published
12 Dec 2011

Med. Chem. Commun., 2012,3, 28-38

From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling

M. P. A. Sanders, R. McGuire, L. Roumen, I. J. P. de Esch, J. de Vlieg, J. P. G. Klomp and C. de Graaf, Med. Chem. Commun., 2012, 3, 28 DOI: 10.1039/C1MD00210D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements